All Industries

Top Biotech Companies

5,081 Biotech companies, sorted by total funding raised.

Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$614.0M·Nov 2021
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Century TherapeuticsIPO

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies for cancer and auto...

Philadelphia, United States51–200Biotech, Healthcare
Corporate Round·$605.0M·Jan 2026
CRISPR Therapeutics AG Common SharesIPO

Gene editing company using CRISPR/Cas9 technology to develop transformative medicines for serious...

Zug, Switzerland201–500Biotech, Healthcare
Venture Round·$604.5M·Feb 2024
TrialSpark

Clinical trial site network and operations

New York, United States51–200Biotech, Healthcare
Series C·$598.0M·Jan 2024
Edgewise TherapeuticsIPO

Clinical-stage biopharmaceutical company developing oral therapies for serious skeletal and cardi...

Boulder, United States51–200Biotech, Healthcare
Growth Equity·$585.0M·Apr 2025
ImmunovantIPO

Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...

New York, United States51–200Biotech, Healthcare
Angel·$585.0M·Oct 2019
UPSIDE Foods

A pioneer in the cell-based meat industry.

Berkeley, United States201–500Biotech, Food Tech
Series C·$583.0M·Apr 2022
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech, Genetics
Series D·$583.0M·Sep 2025
C
Corxel

Biopharmaceutical company

United States51–200Biotech
Series D·$581.5M·Jan 2026
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, GI Health
Venture Round·$580.3M·Jan 2026
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series F·$575.0M·Jan 2026
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

Cambridge, United States51–200Biotech, Healthcare
Series C·$572.6M·Jan 2025
Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech developing novel small molecule medicines using s...

Cambridge, United States51–200Biotech, Healthcare
Growth Equity·$572.0M·Sep 2023
Elevate Bio

ElevateBio is a technology-driven company that partners with innovators to develop transformative...

Waltham, United States201–500Biotech, Healthcare
Series D·$571.0M·May 2023
Orca Bio

Clinical-stage biotech developing high-precision allogeneic cell therapies to replace diseased bl...

Menlo Park, United States51–200Biotech, Healthcare
Series F·$567.0M·Dec 2025
LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Round·$563.0M·Aug 2026
BT
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private Equity·$555.0M·Jan 2024
Freenome

AI-powered multiomic liquid biopsies for early cancer detection

South San Francisco, United States501–1000Artificial Intelligence, Healthcare
Series E·$554.0M·Feb 2024
KardiganIPO

Cardiovascular drug development company focused on making cardiovascular disease curable and prev...

South San Francisco, United States51–200Biotech, Healthcare
Series B·$554.0M·Oct 2025
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
Guardant HealthIPO

Guardant Health is an oncology company.

Palo Alto, United States1001–5000Biotech, Healthcare
Series E·$550.0M·May 2017
Arcus BiosciencesIPO

Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...

Hayward, United States201–500Biotech, Healthcare
Corporate Round·$544.0M·Jan 2024
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United StatesBiotech
Series E·$543.0M·Aug 2026
GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord))Acquired

Genomics and data analytics company providing drug discovery and development services to global b...

Cambridge, United StatesBiotech, Healthcare
Series C·$530.0M·Nov 2018